Optimi Health Corp. (OPTH) Stock Ticker
Market factors today
Unlock the full OPTH picture
About Optimi Health Corp.
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
OPTH stock facts
| Ticker symbol | OPTH |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market cap | $15.5M |
| CEO | Dane Stevens |
| Employees | 6 |
| Headquarters | Princeton, BC, CA |
| IPO date | 2026-05-20 |
| Website | www.optimi.net |
What you can see for OPTH on Tickr
Live OPTH price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the OPTH report.
Rankings
FAQ
What is the ticker symbol for Optimi Health Corp.?
The ticker symbol for Optimi Health Corp. is OPTH, listed on the NASDAQ Capital Market.
What is OPTH?
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio…